Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Thymus Neoplasms

• Application of 68Ga-Pentixafor PET/CT for Thymoma
• Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
• The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train
• A Study of KC1036 in Patients With Advanced Thymic Tumors
• A Phase II, Open-Label Trial of PT-112 in Subjects With Thymoma and Thymic Carcinoma
• Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
• Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma
• Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
• Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
• Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
• Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors
• neoadjuvant_thymic Epithelial Tumor
• Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor
• Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma
• Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)
• Feasibility Trial of Pembrolizumab in Unresectable Thymoma and Thymic Carcinoma
• A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor
• Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy
• Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
• A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
• Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
• Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
• Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
• A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor
• Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin
• Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
• Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy
• A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
• Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
• Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size
• Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
• 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
• A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
• Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
• Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
• Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
• Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
• A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
• Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
• High Dose Somatostatin Analogues in Neuroendocrine Tumors
• Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
• Paclitaxel and Cisplatin for Thymic Neoplasm
• Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
• Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage
• Preoperative Treatment of Patients With High Risk Thymoma
• A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
• Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
• Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
• Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma